Air fluidized therapy beds sales will strengthen through 2036, anchored by hospitals at a 65.0% share in 2026 as the leading end user segment. The market is expected to reach USD 771.7 million in 2026 and USD 1343.4 million by 2036, creating an absolute opportunity of USD 571.7 million.